Fremanezumab for the Treatment of Migraine and Major Depressive Disorder

Fremanezumab for the Treatment of Migraine and Major Depressive Disorder

JAMA Network... · 21:12 · 1 400 écoutes

De l'album JAMA Neurology Author Interviews

Description

Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD. Related Content: Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder

More By JAMA Network...

1
AlbumJAMA Neurology Author Interviews
JAMA Network... · 3 934 écoutes
2
Acoustic Analysis of Primary Care Patient–Clinician Conversations to Screen for Cognitive Impairment
JAMA Network... · 5 174 écoutes · 22:39
3
Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome
JAMA Network... · 2 840 écoutes · 14:18
4
Epstein-Barr Virus Antibodies and Multiple Sclerosis
JAMA Network... · 3 146 écoutes · 14:58
5
Location and Timing of Recurrent, Nontraumatic Intracerebral Hemorrhage
JAMA Network... · 1 890 écoutes · 15:56
6
US Burden of Disorders Affecting the Nervous System
JAMA Network... · 3 738 écoutes · 23:32
7
Smoking, Exhaled Carbon Monoxide, and Risk of Parkinson Disease
JAMA Network... · 3 955 écoutes · 19:27
8
Phenoconversion in Pure Autonomic Failure
JAMA Network... · 1 020 écoutes · 24:00
9
Direct-Acting OACs and Antiseizure Medications for AF and Epilepsy and Risk of Thromboembolic Events
JAMA Network... · 1 914 écoutes · 19:31
10
Early Pregnancy Use of Anti-CGRP Monoclonal Antibodies and Propranolol and Spontaneous Abortion Risk
JAMA Network... · 2 967 écoutes · 22:32

Vous aimerez aussi